Trial intelligence / Profile preview

ADRC vs CAF for Unilateral Vocal Cord Paralysis

NCT02904824Phase 2Completed

Sponsor
Gregorio Marañón University General Hospital
Start
Jul 2012
Primary completion
Sep 2014
Modality
Stem Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of autologous adipose-derived stem/stromal cells in unilateral vocal cord paralysis (UVCP), sponsored by Gregorio Marañón University General Hospital. Started Jul 2012; status: completed.

02

Drugs

autologous adipose-derived stem/stromal cells
03

Conditions

unilateral vocal cord paralysis (UVCP)

Beyond the preview

Go deeper on NCT02904824.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02904824.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call